학술논문
Sequential intravesical gemcitabine/docetaxel provides a durable remission in recurrent high-risk NMIBC following BCG therapy
Document Type
Article
Author
Source
In: Urologic Oncology: Seminars and Original Investigations . (Urologic Oncology: Seminars and Original Investigations, November 2023, 41(11):458.e1-458.e7)
Subject
Language
English
ISSN
18732496
10781439
10781439